About Dr. Kiran Kumar DVS
Dr. Kiran Kumar DVS is a highly respected and leading Medical Oncologist in Chennai, deeply invested in the dynamic field of oncology and committed to delivering the highest standards of patient care. As a top oncologist in India, his expertise spans Immuno-oncology, Precision Oncology, Hemato-oncology, and Hereditary Cancer. Dr. Kumar has garnered significant academic and research accolades, including multiple university gold medals and the Tamil Nadu Dr. M.G.R. Medical University Best Researcher Award. With a patient-focused approach and a strong background from prestigious institutions like Christian Medical College, Vellore, and Cancer Institute (WIA), Chennai, he is a sought-after specialist for comprehensive and cutting-edge cancer treatment.
Qualifications & Credentials
- MBBS
- MD Internal Medicine
- DM Medical Oncology
- MRCP - Royal College of Physicians of Edinburgh
- Certificate course in Essentials of Palliative Care - Karunashraya Hospice, Bengaluru
- Basic Course in Bio-medical Research - ICMR
Areas of Expertise
- Various solid organ malignancies (including paediatric cancers)
- Haematological malignancies
- Immuno-oncology
- Precision Oncology
- Hemato-oncology
- Hereditary Cancer
- Systemic therapy in asymptomatic brain metastases
- Palliative chemotherapy management
- Metronomic chemotherapy for advanced cancers
- Targeted and immunotherapy drug management
Professional Experience
- Consultant & Head – Medical Oncology, Sringeri Sharada Equitas Hospital, Chennai (Sep 2023 - Present)
- Consultant Medical Oncologist, Apollo Proton Cancer Centre, Chennai (Jul 2023 - Sep 2023)
- Associate Consultant Medical Oncologist, Apollo Proton Cancer Centre, Chennai (Jul 2022 - Jun 2023)
- Assistant Professor, Department of Medical Oncology, Sri Venkateswara Institute of Medical Sciences (SVIMS), Tirupati (Jan 2021 - Jun 2022)
- Senior Resident, AIIMS (All India Institute of Medical Sciences), New Delhi (Apr 2017 - Aug 2017)
- Senior Resident, Department of Medicine, AIIMS, New Delhi (2016-2017)
- Involved in teaching of registrars and research work during Senior Residency at AIIMS.
- Numerous publications and presentations in national and international conferences.
- Co-author in various research papers.
- Independent clinical work in OPD, emergency department, ICU, and wards.
- Served as a specialist Medical doctor during Amarnath Yatra in Chandanwari valley, 2017.
- Actively involved in clarifying myths related to breast cancer to spread awareness.
- Presented on Systemic therapy in Asymptomatic Brain metastases at the Apollo Radiosurgery Conclave.
- Involved in studies related to treatment-related necrosis in glioma, concurrent Pazopanib with Radiotherapy, and access to targeted/immunotherapy drugs.
- Presented in ASCO 2023 on the effectiveness of dexamethasone in reducing cancer-associated fatigue.
Awards & Recognitions
- Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU) Best Researcher Award 2024 (2nd place)
- State Gold Medal for Best Outgoing student in MBBS (2011)
- University Gold Medal in Obstetrics and Gynecology (MBBS 2011)
- University Gold Medal in Anatomy (MBBS 2007)
- University Gold Medal in Physiology (MBBS 2007)
- University Silver Medal in Medicine (MBBS 2011)
- Second place in National TYSA (Torrent Young Scholar Award) in Medical Oncology (2019)
- Best poster award in Pediatric hemato-oncology conference, Bangalore (2018)
- Second place in NCRM (Niche-in centre for regenerative medicine) National level quiz in regenerative medicine (2008)
- Stood first in the Golden Jubilee Quiz at SV Medical College (2010)
- Presented poster in International Conference- SIOP-Asia, Abu Dhabi (2019).
- Received Award for Professional Excellence from the Tamil Nadu Medical Council from the Governor at the Raj Bhavan.
Research & Publications
- Drawback of chimerism analysis by XY-fluorescence in situ hybridization: Deception of a relapse. Indian J Med Paediatr Oncol (2020;41:621-3).
- Incidence, risk factors and complications of dysphagia in stroke patients admitted to medical wards at a tertiary hospital in South India. (Doctoral dissertation, Christian Medical College, Vellore).
- CRAB Manifestations in a Middle-Aged Female: A Diagnostic Dilemma. Journal of The Association of Physicians of India (2018 Jan;66:86).
- Efficacy And Toxicity Of Oral Metronomic Chemotherapy In Paediatric Solid Organ Malignacies-Experience From Tertiary Centre Over 8 Years. Pediatric Hematology Oncology Journal (2018 Jan 1;3(3):S49).
- Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers. Cancer Res Stat Treat (2020;3:64-8).
- Presented in ASCO 2023 - Phase 3 randomized controlled trial comparing the effectiveness of dexamethasone in reducing cancer-associated fatigue in patients on palliative chemotherapy.
- Co-investigator in institutional and multi-centric studies (inferred from AIIMS experience).
Patient Success Stories & Testimonials
- Successful management of various complex solid organ and haematological malignancies.
- Expertise in tailoring systemic therapies for diverse cancer presentations, including those with asymptomatic brain metastases.
- Involvement in the development of low-cost palliative metronomic chemotherapy for paediatric cancers.
- Active in public health initiatives, including breast cancer awareness campaigns.
Treatment Approach & Philosophy
Treatment Costs
| Treatment Type | Estimated Cost (INR) | Estimated Cost (USD) |
| Chemotherapy Cycle (Standard) | 25,000 - 1,50,000 | 300 - 1,800 |
| Immunotherapy Cycle | 1,50,000 - 5,00,000 | 1,800 - 6,000 |
| Targeted Therapy (monthly) | 50,000 - 3,00,000 | 600 - 3,600 |
| Precision Oncology Diagnostics (initial) | 40,000 - 1,00,000 | 480 - 1,200 |
| Haematological Malignancy Treatment (initial) | 2,00,000 - 8,00,000 | 2,400 - 9,600 |









